With a string of news coming from drug firm Lupin, the company further expects about 14 to 15 launches in the course of this year. Company’s CFO, S Ramesh tells CNBC-TV18 that the company has a pipeline of over 150 drugs that await approval for the American market from the US Food and Drug Administration (FDA).
first published: Jun 23, 2011 03:44 pm
A collection of the most-viewed Moneycontrol videos.
SOBO to Bandra: Why Only South Mumbai Residents Call Bandra a Downgrade | The Tenant
Live: Nifty registers third straight week of gains, up 2% in November | Closing Bell
Live: Can Nifty continue to step up its move to fresh peaks? | Opening Bell
Live: Sensex, Nifty retreat after mounting on new lifetime highs | Closing Bell
